ENDRA Life Sciences Inc. Income Statement

Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.52M0.35M0.01M0.46M0.11M
Cost of Revenue 0.03M0.17M0.26M0.41M0.58M1.08M1.43M0.82M0.57M
Gross Profit 0.28M0.18M0.01M0.46M0.11M
Operating items
Amortization - Intangibles 0.73M2.36M0.23M
Research & Development 0.50M1.93M4.72M6.57M5.92M5.48M6.55M5.00M3.19M
Selling, General & Administrative 1.54M2.75M3.75M3.86M5.00M4.94M5.17M4.70M7.06M
Other Operating Expenses 0.03M0.12M0.55M0.41M0.58M1.08M1.43M0.82M0.57M
Operating Expenses 2.07M4.80M9.03M10.84M11.50M11.50M13.16M10.52M10.82M
Operating Income -1.79M-4.63M-9.02M-10.84M-11.50M-11.50M-13.16M-10.52M-10.82M
EBIT -1.79M-4.63M-9.02M-10.84M-11.50M-11.50M-13.16M-10.52M-10.82M
Non-operating items
Other Non Operating Income -0.75M-0.05M-0.11M0.01M-0.31M-0.02M0.46M-0.69M
Non Operating Income 0.98M-0.75M-0.78M-2.46M-0.22M0.27M-0.02M0.46M-0.69M
Net income details
EBT -2.78M-5.38M-9.80M-13.31M-11.73M-11.23M-13.18M-10.06M-11.51M
Profit After Tax -2.78M-5.38M-9.80M-13.31M-11.73M-11.23M-13.18M-10.06M-11.51M
Income from Continuing Operations -2.78M-5.38M-9.80M-13.31M-11.73M-11.23M-13.18M-10.06M-11.51M
Consolidated Net Income -2.78M-5.38M-9.80M-13.31M-11.73M-11.23M-13.18M-10.06M-11.51M
Income towards Parent Company -2.78M-5.38M-9.80M-13.31M-11.73M-11.23M-13.18M-10.06M-11.51M
Preferred Dividend Payments 4.22M0.40M
Net Income towards Common Stockholders -2.78M-5.38M-9.80M-17.53M-12.12M-11.35M-13.18M-10.06M-11.51M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.54M
EBITDA -1.79M-4.63M-9.02M-10.84M-11.50M-11.50M-13.16M-10.52M-10.82M